Theme: Innovative Therapeutic Strategies in Vaccines & Vaccination

Vaccines Congress -2016

Vaccines Congress -2016

Conferenceseries LLC Conferences invites all the participants from all over the world to attend “14th Global Vaccines & Vaccination Summit and Expo” December 05-06, 2016 Dubai, UAE. This includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.  The aim of Vaccines Congress is to bring together leading academic Scientists, Researchers, professors, Business delegates, talented student communities and research scholars to commerce and share their experiences and research conclusion about all aspects of Vaccination & Therapeutics research.

Vaccines Congress-2016 hosting presentations from Global Leaders in the field across the Globe and bringing together vaccine stakeholders including academic researchers, public health clinicians, vaccine policy makers, corporate and vaccine manufacturers. There will be opportunities for those selected to present at the meeting to also publish a manuscripts and abstracts from their talk in the Journal of Vaccines and Vaccination or its sister publication Immunome Research. Conferenceseries LLC organizes 1000+ Conferences every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Track 1: Vaccine development:

Vaccine research is long, complex and costly. Because a vaccine is a biological product made from living microorganisms, its development method is quite different from that of a pharmaceutical method. Approximately 70% of production time is dedicated to quality control, Vaccine development is a long, complex process, often lasting 10-15 years and involving a combination of public and private involvement. Vaccine development and testing follow a standard set of steps.

1. Laboratory Studies and Animal Studies: Exploratory Stage, Pre-clinical Stage, IND Application

2. Clinical Studies with Human Subjects: Phase I Vaccine Trials, Phase II Vaccine Trials, Phase III Vaccine Trials,

3. Approval and Licensure

4. Post-Licensure Monitoring of Vaccines

5. Phase IV Trials

VAERS: The Vaccine Adverse Event Reporting System

Related Conferences:

Geriatric Medicine Conference, Nov 17-19, 2016, USA; 3rd International Conference on Geriatrics & Gerontology, Aug 15-17, 2016, UK; 13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia; Australian and New Zealand Society of Geriatric Medicine (ANZSGM) Annual Scientific Meeting 2016, Australia; National Adult and Influenza Immunization Summit Meeting, Georgia; American Geriatrics Society Annual Scientific Meeting 2017, USA; Immunisation of adults and elderly: How to make life course vaccination a successful public health strategy, Poland; 24th Annual Issues & Strategies in Adult Vaccine Preventable Diseases, MN, Vaccines Conferences, June 16-18, 2016, Holiday inn Rome - Aurelia, Rome, Italy

Track 2: Vaccine Business:

The Evolution in the Vaccines market continues with strong growth and new prospects to continue the growth in Vaccines market, which now stands at about $25 billion. The market is expected to return a compound annual growth rate of more than 8% through 2018, Evaluate projects, with some segments like adult vaccines showing even better.

                           The major growth in vaccine sales has been in the adult influenza market with the big focus on flu prevention and an acceptance of adult vaccines. The Centers for Disease Control and Prevention (CDC) recently noted that only 56% of people who received the jab were protected from influenza, here we present the Top 5 vaccine companies based on their 2012 vaccine revenues, as they are of, Sanofi, Merck, GlaxoSmithKline, Pfizer, Novartis. While vaccine prices have always been higher in the middleeast countries due to tiered pricing, prices have been rising dramatically in recent years.

Related Conferences:

Annual Conference on H1N1 & Influenza Vaccines, July 25-26, 2016, USA; 11th Global Summit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; 13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia; Vaccines R&D-A New Era in Vaccine Discovery Baltimore, USA; 18th Annual Conference on Vaccine Research Bethesda, USA; 13th Vaccines Research & Development: All Things Considered Conference Boston, USA; 16th Annual Conference on Vaccine Research Baltimore, USA; Ebola 2015 Oxford, UK; 13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016; The Arthropod Vector: The Controller of Transmission (E2), USA; 3rd Conference on Neglected Vectors and Vector-Borne Diseases, Spain, Vaccines Conferences, June 16-18, 2016, Holiday inn Rome - Aurelia, Rome, Italy

Track 3: Novel Vaccines against Infectious Diseases:

Vaccination, leading to the eradication of naturally occurring air borne diseases, the near elimination of polio and the control of diseases. The potential introduction of viruses into the sustained circulation among populations of immunologically active, healthy and susceptible hosts. The induction of protective immunity through vaccination by using Vaccines can be a powerful tool to prevent this act by conferring protection to the population at risk is due to the lack of experimental tools for several viruses, lack of concern, poor immunogenicity, safety issues.

Related Conferences:

Annual Conference on H1N1 & Influenza Vaccines, July 25-26, 2016, USA; 11th Global Summit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; 13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia; Vaccine Summit, UK; BIT's 6th Annual World Congress of Vaccine, Dalian, China; New Approaches to Vaccines for Human and Veterinary Tropical Diseases, South Africa; 9th Vaccine & ISV Congress, South Korea; World Vaccine Congress, USA, Vaccines Conferences, June 16-18, 2016, Holiday inn Rome - Aurelia, Rome, Italy

Track 4: Adult Immunization Challenges:

Looking forward at vaccine-preventable diseases, findings at the pre vaccine era and the year, you can see virtually that all the vaccine-preventable diseases for which there were current vaccines, they have been decreased by 99% to 100%. we might be forgetting about one of the simplest preventive care measures available is of vaccination. Keeping up to date with your vaccinations is a great way to stay healthy, through the use of vaccines, measles and rubella have been eliminated in many areas, polio has been eliminated from most of the world, and smallpox has been completely eradicated. The reasons for low adult vaccination rates, indicating adult Immunization challenges like one challenge is that payment for adult vaccination can be confusing, the other one is  the adult vaccination schedule is much more complicated than the childhood vaccination schedule, with certain vaccines needed at certain times, depending on age, living conditions and health conditions.

Related Conferences:

Annual Conference on H1N1 & Influenza Vaccines, July 25-26, 2016, USA; 11th Global Summit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; 13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia; Vaccine Summit, UK; BIT's 6th Annual World Congress of Vaccine, Dalian, China; New Approaches to Vaccines for Human and Veterinary Tropical Diseases, South Africa; 9th Vaccine & ISV Congress, South Korea; World Vaccine Congress, USA, Vaccines Conferences, June 16-18, 2016, Holiday inn Rome - Aurelia, Rome, Italy

Track 5: Diabetes Vaccines:

Vaccines have greatly eliminated many infectious diseases that once routinely killed or harmed many infants, children, and adults. Viruses and bacteria that cause vaccine-preventable disease still exist and can be allowed to pass on to people who are not protected by vaccines.  Vaccines work with the body's natural defenses to safely develop immunity and suffering from their effects.     

  Type 1 diabetes is an autoimmune disease which, causes the body’s own ‘killer’ T cells to kill off the pancreas’s insulin which produces beta cells. Diabetes vaccines help to stop the T cells from attacking the body's own cells.

  Type 2 diabetes mellitus is a metabolic disorder results in hyperglycemia (high blood glucose levels) due to the body being ineffective at using the insulin and unable to produce enough insulin,

Type 2 diabetes earlier known as non-insulin dependent diabetes due to its occurrence mainly in people over 40.

Related Conferences:

Annual Conference on H1N1 & Influenza Vaccines, July 25-26, 2016, USA; 11thGlobal Summit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; 13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia; RSV vaccines for the World, USA; Influenza Vaccines for the World, Portugal; Pathogenesis of Respiratory Viruses, USA; Influenza Vaccines, Bangkok, Thailand; Third isirv-Antivirals Group Conference: Influenza and Other Respiratory Virus Infections: Advances in Clinical Management, Japan, Vaccines Conferences, June 16-18, 2016, Holiday inn Rome - Aurelia, Rome, Italy

Track 6: Veterinary Vaccines:

The major goal of veterinary vaccines is to improve the health and welfare of companion animals, increase production of livestock in a cost-effective way, and prevent animals to human transmission from both domestic animals and wildlife. The strain of rabies virus used and that of the characteristics of the cell substrate chosen for viral replication, highly immunogenic and  inactivated cell culture vaccines for immunization of dogs and the parenteral route are now widely available on the international market at cost affordable. In addition the trend towards transfer of modern cell culture method for the parenteral veterinary vaccine production is increasing in developing countries particularly in Asia.

Related Conferences:

Annual Conference on H1N1 & Influenza Vaccines, July 25-26, 2016, USA; 11thGlobal Summit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; 13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia; Biomarkers of Vaccine/Adjuvant Potency and Safety, Portugal; Modern Vaccines Adjuvants Formulation, Denmark; The Modes of Action of Vaccine Adjuvants (S1), USA; Modern Vaccines Adjuvants & Drug Delivery Systems, The Netherlands; 4th International Conference: Modern Vaccines/Adjuvants Formulation-Impact On Future Development, Switzerland,Vaccines Conferences, June 16-18, 2016, Holiday inn Rome - Aurelia, Rome, Italy

 

Track 7: Therapeutic Vaccines for Chronic Infections:

Therapeutic vaccines mainly aim to prevent severe complications of a chronic infection by reinforcing host defenses when some immune control, albeit insufficient, can be demonstrated using the vaccinia cowpox virus, Jenner was able to protect vaccines from variola or smallpox. The Modified Virus Ankara (MVA) poxvirus strain which is one of the vaccines developed to prevent smallpox infection and was selected by the US government in their Biodefense strategy.

Related Conferences:

Annual Conference on H1N1 & Influenza Vaccines, July 25-26, 2016, USA; 11thGlobal Summit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; 13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia; Vaccine Technology VI, Portugal; Vaccine Innovation Conference Toronto; Emerging Technologies Conference Cambridge, USA; The Universe of Prefilled Syringes & Injection Devices Vienna, Austria, Vaccines Conferences, June 16-18, 2016, Holiday inn Rome - Aurelia, Rome, Italy

Track 8: Cancer Vaccines / AIDS/HIV Vaccines:

HIV vaccine is a type vaccine which would either protect individuals who do not have HIV from contracting that virus, Cancer vaccines are of medicines that belong to a class of substances known as biological response modifiers. This modifiers work by stimulation and restoring the immune system’s ability to fight infections and disease. There are two broad types of cancer vaccines:

2 types of cancer vaccines

1. Preventive (or prophylactic) vaccines

2. Treatment (or therapeutic) vaccines,

Related Conferences:

Annual Conference on H1N1 & Influenza Vaccines, July 25-26, 2016, USA; 11th Global Summit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; 13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia; Vaccines R&D-A New Era in Vaccine Discovery Baltimore, USA; 18th Annual Conference on Vaccine Research Bethesda, USA; 13th Vaccines Research & Development: All Things Considered Conference Boston, USA; 16th Annual Conference on Vaccine Research Baltimore, USA; Ebola 2015 Oxford, UK, Vaccines Conferences, June 16-18, 2016, Holiday inn Rome - Aurelia, Rome, Italy

Track 9: Immuno-Informatics in Vaccine Designs:

The regions which are termed as epitopes, are ideal components of vaccines. When the different new tools are used for the search of epitopes, this search is usually coupled with in vitro screening methods; an approach has been termed computational immunology immuno-informatics. The active agent of a vaccine may be intact but it is inactivated (‘attenuated’) forms of the causative pathogens.

Types of vaccines

1.  Inactivated vaccines

2. Live attenuated vaccines

3. Subunit vaccines

4. Virus-like particles

Related Conferences:

Annual Conference on Virulent HIV Vaccines, July 28-30, 2016 Thailand; Annual Conference on H1N1 & 1Influenza Vaccines, July 25-26, 2016, USA; 11th Global Summit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA;  HIV Vaccines (X8), USA; HIV Persistence: Pathogenesis and Eradication (X7), USA; American Conference for the Treatment of HIV, USA; The 20th International AIDS Conference, Australia; 2015 National HIV Prevention Conference, USA, Vaccines Conferences, June 16-18, 2016, Holiday inn Rome - Aurelia, Rome, Italy

Track 10: Immunology / animal models:

A model organism is a non-human species that is extensively studied to understand particular biological phenomena, with the expectation that discoveries which made in the organism model will provide insight into the different workings of other organisms. It deals with the physiological functioning of the immune system, in states as of both health and diseases, failure of the immune system results in the immunological disorders, which will affect the physical, chemical and physiological characters of the components of the immune system in vitro, in situ and in vivo.

Related Conferences:

Annual Conference on H1N1 & Influenza Vaccines, July 25-26, 2016, USA; 11th Global Summit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; 13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia; Tuberculosis Co-Morbidities and Immunopathogenesis (B6), USA; 5th Asian Vaccine Conference, Vietnam; Tuberculosis Vaccines 2015, Shanghai; 8th International Workshop on Clinical Pharmacology of Tuberculosis Drugs , USA; 46th Union World Conference on Lung Health, South Africa, Vaccines Conferences, June 16-18, 2016, Holiday inn Rome - Aurelia, Rome, Italy

Track 11: Vectors / adjuvants / drug delivery:

An adjuvant is any compound that enhances the immune response against a vaccine antigen. In many cases, the antigen itself is immunogenic; therefore an adjuvant is needed to intensify the immune response. Adjuvants can also be included in vaccine, as of which can guide the immune response  which could be generated, Potent adjuvants enhances the effectiveness of vaccines which accelerates  the generation of robust immune responses, the sustaining responses for a longer duration and inducing local mucosal immune responses, thus generating antibodies with increased affinity and neutralization capacity.

Related Conferences:

Annual Conference on H1N1 & Influenza Vaccines, July 25-26, 2016, USA; 11thGlobal Summit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; 13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia; The Arthropod Vector: The Controller of Transmission (E2), USA; 3rd Conference on Neglected Vectors and Vector-Borne Diseases, Spain; Emerging Vector-borne Diseases in a Changing European Environment, France; The XIX International Congress for Tropical Medicine and Malaria, Australia; 18th Annual Conference on Vaccine Research, USA, Vaccines Conferences, June 16-18, 2016, Holiday inn Rome - Aurelia, Rome, Italy

Track 12: Childhood Immunization Challenges:

The most important challenge today is to keep up the awareness and interest momentum among governments, donors and health personnel until basic immunization services are attained, more than 30 million children still without the most basic protection provided by vaccines. Approximately 40% of children are under immunized state. One of the leading reasons for this is a lack of understanding by parents on the importance of childhood vaccines and lack of importance about vaccines, The primary barrier is of immunization, which we found were parental doubt about vaccine importance, decreased communication with providers, the need to reschedule appointments, and problems scheduling appointments, enhance the immunity.

Related Conferences:

Children Vaccines Conference, Oct 10-12, 2016 Rome, Italy; Annual Conference on H1N1 & Influenza Vaccines, July 25-26, 2016, Chicago, USA; 13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Melbourne, Australia; Vaccines for Children & Vaccine Preventable Disease Conference South Iselin, NJ; Infectious Diseases in Children A Primary Care and Hospitalist Approach Florida, USA; Colorado Regional Immunization Summit 2015 Grand Junction, CO; 20th Annual Massachusetts Immunization Action (MIAP) Pediatric Immunization Skills Building Conference Marlborough, Massachusetts; GAVI Pledging Conference 2015 Berlin, Germany, Vaccines Conferences, June 16-18, 2016, Holiday inn Rome - Aurelia, Rome, Italy

Track 13: Vaccines for pregnant women:

Some of the vaccines, such as the measles, mumps, rubella (MMR) vaccine, should be given a month or more before pregnancy. Vaccines some should get while pregnancy are like T dap which protect against whooping cough, at time during pregnancy. Some other vaccines like the flu shot, can be given before or during pregnancy, which depend upon the whether or not its flu season, when you’re pregnant. There are mostly 2 vaccines routinely recommended during pregnancy time, those are of flu and Tdap.

Pneumococcal vaccine, is used at time, which is high risk of pneumococcal disease

Related Conferences:

Pregnancy Summit & Child Health, Aug 29-31, 2016, Brazil; Annual Conference on H1N1 & Influenza Vaccines, July 25-26, 2016, USA; 13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination, Nov 10-12, 2016, Australia; Harmonization Safety Monitoring of Immunization in Pregnancy - International Consensus Conference, USA; Massachusetts Adult Immunization Conference, USA; 2nd IFCC-OCD Conference on Pregnancy Related Disorders, Paris; Safety Monitoring of Immunization in Pregnancy International Consensus Conference, USA; Regional, Vaccines Conferences, June 16-18, 2016, Holiday inn Rome - Aurelia, Rome, Italy

 

 

 

Conferenceseries LLC invites all the participants from all over the world to attend “14th Global Vaccines & Vaccination Summit and Expo” December 05-06, 2016 Dubai, UAE. This includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.  The aim of Vaccines Congress is to bring together leading academic Scientists, Researchers, professors, Business delegates, talented student communities and research scholars to commerce and share their experiences and research conclusion about all aspects of Vaccination & Therapeutics research.

Vaccines Congress-2016 hosting presentations from Global Leaders in the field across the Globe and bringing together vaccine stakeholders including academic researchers, public health clinicians, vaccine policy makers, corporate and vaccine manufacturers. With the generous response and support received from the participants of previous annual vaccines conferences. Conferenceseries LLC organizes 1000+ Conferences every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Why to attend???

Vaccinology/Immunology and its advances, Immunology mainly deals about the structure and function of the immune system. Vaccinology is the science of vaccine development, the participation at this scientific field is your best opportunity to reach the participants from the Immunology/Vaccinology fields from all over the world. It is a global gathering of people from different Immunology areas on to a single platform, conduct presentations, transform information, meet with Eminent and potential scientists, exploring with new vaccines research work and developments, and receive a unique recognition at this event. World-renowned speakers, the most recent techniques, developments in the Vaccines field, discoveries and the current updates and technology in Immunology/Vaccinology are hallmarks of this conference.

Target Audience:

    Vaccinology/Immunology, Scientists
    Vaccinology Researchers
    Vaccinology Faculty
    Medical Colleges Faculty, Students
    Immunology Associations and Societies
    Business Entrepreneurs
    Vaccines Training Institutes
    Software developing companies
    Manufacturing Medical Devices Companies
    Clinical Data Management Companies
    Machinery Manufacturing Companies

 

 

“14th Global Vaccines & Vaccination Summit and Expo” to be held at Dubai, UAE during December 05-06, 2016 hosted by Conferenceseries LLC, the conference will explore the advances in Vaccines and vaccination. This conference could be an exceptional event that brings along a novel and International mixture of giant and medium cognizance on vaccines and vaccination, leading universities engendering the conference an ideal platform to apportion expertise, foster collaborations across trade and world, and assess elevating technologies across the world. Conferenceseries LLC organizes 1000+ Conferences every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Vaccination is a key to eradicate the diseases. It is a subject for the professionals who looks beyond the clinical prospects. Vaccines Congress-2016 amasses all the extroverts under one roof of current advances.

For more details please visit- http://vaccines.global-summit.com/middleeast/

      Vaccinology is a major field in eradication of diseases. Traditional approaches to vaccine design were to emasculate or inactivate the human pathogen or a cognate animal homologue, Vaccinology is the science of vaccine development and how the immune system responds to vaccines, but additionally includes perpetual evaluation of immunization programs and vaccine safety and efficacy, as well as surveillance of the epidemiology of vaccine-preventable diseases. This chapter provides a brief overview of some of the main concepts of immunology and Vaccinology as they relate to immunization.

Conference Highlights: 

  • Novel Vaccines against Infectious Diseases 
  • Adult Immunization Challenges
  • Diabetes Vaccines
  • Veterinary Vaccines
  • Therapeutic Vaccines for Chronic Infections
  • Cancer Vaccines / AIDS/HIV Vaccines
  • Immuno-Informatics in Vaccine Designs
  • Immunology / animal models
  • Vectors / adjuvants / drug delivery
  • Childhood Immunization Challenges
  • Vaccines for pregnant women
  • Vaccine development

Why to attend???

Vaccines Congress-2016  could be an event that brings along a novel and International mixture of giant and medium Vaccinology innovation and incipient trends in vaccines and vaccination, leading universities and Vaccinology, vaccination research analysis establishments creating the conference an ideal platform to share expertise, foster collaborations across trade and world, and assess rising technologies across the world. World-renowned speakers, the most recent techniques, tactics, and the newest updates in Vaccinology research are hallmarks of this conference.

A Unique Opportunity for Advertisers and Sponsors at this International event:

http://vaccines.global-summit.com/middleeast/sponsors.php

Major Vaccines Associations Globally

  • The International Society for Interferon and Cytokine Research
  • The International Society of Neuroimmunology
  • The International Union of Immunological Societies
  • The Society for Mucosal Immunology
  • The Society for Leukocyte Biology
  • Transplantation Society
  • British Society for Immunology
  • Cell Death Society
  • European Federation of Immunological Societies
  • European Society of Gene Therapy
  • Federation of African Immunological Societies
  • Federation of American Societies for Experimental Biology
  • Federation of Clinical Immunology Societies
  • Immune Deficiency Foundation
  • Infectious Diseases Society of America

Target Audience:

Vaccines Congress-2016  Targets: CEO’s, Directors, Scientists, Professors, Students of all Biotech & Pharma companies, Universities and colleges globally

Vaccines sales in global leader companies 2012:

  • Pfizer 2.2 B $
  • Sanofi 1.7 B $
  • Merck & Co 1.8 B $
  • GSK 2.5 B $
  • Novartis 0.44 B $
  • EBS 0.88 B $

Top Global Immunology Universities:

   Rank          University Name

1              Harvard University

2              University of California--San Francisco

3              Stanford University

3              Yale University

5              Johns Hopkins University

5              Washington University in St. Louis

7              Duke University

7              University of Pennsylvania

9              University of Texas Southwestern Medical Center 

Companies Associated with Vaccines

  • CareDx
  • Atara
  • Biotherapeutics
  • Benitec Limited  
  • InterMune
  • Biotron Limited
  • BioDiem
  • Antisense Therapeutics Limited           
  • GlaxoSmithKline Australia Pty Ltd
  • Bionomics
  • Australian Pharmaceutical Industries (API)   
  • BioPharmica Limited

Market Analysis of Vaccines

Tripled in value from USD 5B in 2000 to almost USD 24 B in 2013, Global market projected to rise to USD 100 B by 2025. More than 120 new products in the development pipeline. 60 are of importance for developing countries. UNICEF had a market of 1, 03 B$ in 2011, PAHO had 400 million dollars in 2011 and total UN market of 340 million dollars in 2002, 1,430 billion dollars in 2011.

Overall Statistics:

 

Middle East Vaccines-2015

Sensing the raising importance of Vaccines, Conferenceseries LLC hosted the 7th Middle East Global Summit and Expo on Vaccines & Vaccination” (Middle East Vaccines -2015), scheduled from September  28-29, 2015 in Dubai, UAE with a theme “Novel Therapeutic Strategies in Vaccines & Vaccination”.  Benevolent response and active participation was received from the Editorial Board Members of Conferenceseries LLC Journals as well as from the Vaccines project managers, Vaccinologists, Immunologists, Vaccine researchers, scientists, doctors, students and leaders from the fields of Vaccines and Vaccination, Immunology, who made this event successful.

The meeting was carried out through various sessions, in which the discussions were held on the following thought provoking and cerebrating scientific tracks:

  • Technologies for the Design, Discovery, formulation and administration of vaccines.
  • Developing Next-Gen Conjugate Vaccines.
  • New trends in carbohydrate-based vaccines.
  • Vaccines for Pregnant Women.
  • Recent advances in animal vaccination
  • Adjuvants for human vaccines—current status, problems and future prospects.
  • Current developments in bacterial conjugate vaccines potency.
  • Recent trends in attenuated vaccines.
  • Advancements in vaccine development
  • Vaccination and quality of life
  • Protein subunits- vaccination.
  • Toxoid vaccines and its importance
  • Geriatric Immunization
  • Vaccines under research and development, major diseases
  • Innovative development of vaccines

The conference was embarked with an opening ceremony followed by workshop and a series of lectures delivered by both Honorable Guests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talk were;

Dr. Joshy Jacob, Emory University, USA.

Dr. Ahmed Alluwaimi, King Faisal University, UAE.

Dr. Frederic Deschamps, University Hospital of Reims, France.

Young Researchers:

An Immunoinformatics analysis and structure based modeling of potential HLA class II allele binding T cell epitopes for vaccine design of JE

Pawan Sharma, Mangalayatan University,  India.

Conferenceseries LLC offers its heartfelt appreciation to Societies and Organizations, Organizing Committee Members, adepts of field, various outside experts, company representatives and other eminent personalities who interlaced with Conferenceseries LLC in supporting and making the conference as never before one.

Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Vaccines Middle East Vaccines -2015, Conferenceseries LLC is delighted to announce the next event.  Mark your calendars for the upcoming extravaganza," 13th  Global Vaccines & Vaccination Summit and Expo" to be held during November 08-09, 2016 Istanbul, Turkey.

For More details: http://vaccines.global-summit.com/middleeast/2015/

 

 


Past Reports  Proceedings  Gallery  

Click here to submit abstract to any of the above topics

sponsor

Want to Differentiate your company from your competitors and broaden your competitive edge?

Use our global platform of 3000+ Global Events

  • 25 Million+ Visitors to our Global website (conferenceseries.com)
  • 20000+ Unique Visitors per conference
  • 60000+ Page views per conference

For customized sponsorship opportunities at our conferences, or to place an ad on our websites, contact at sponsors@conferenceseries.com or call at: +1-650-268-9744

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date December 05-06, 2016
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Day 1 Day 2 Day 3
Poster Opportunity Available

Media Partners

Conferenceseries Destinations